Takeda at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Takeda brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Takeda's program spans biomarker discovery and nanoparticle manufacturing. Its work covers microRNA patterns in the serum of autoimmune disease patients as possible diagnostics, and a simulation model of tangential flow filtration built from lab data.

OrganizationAAPS 2026 PharmSci 360 Attendance
Takeda
Tokyo, Japan
takeda.com
Large pharma
Global pharmaceutical company focused on gastroenterology, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.
Poster
Mon Oct 26
3:30pm–4:30pm
Exploring the Diagnostic Potential of miRNA Signatures in the Autoimmune Disease Patients Serum
Solution Center · Poster M1530-07-37
Preclinical, Clinical, and Translational Sciences
Poster
Wed Oct 28
10:30am–11:30am
Development of Tangential Flow Filtration (TFF) Simulation Model Based on Experimental Data for Nanoparticle Manufacturing
Solution Center · Poster W1030-07-37
Manufacturing and Analytical Characterization - Biomolecular

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Takeda

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction